Top Markets
Coin of the day
Cognetivity Neurosciences Ltd. Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd.

CGN
Rang in aandelen #39081
Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in... Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in the development of an integrated cognitive assessment platform. This advanced testing system, applicable across medical, commercial, and consumer environments, is designed to identify the earliest indicators of cognitive impairment by evaluating the performance of broad brain regions, thereby aiding in the diagnosis of dementia. The company also offers OptiMind, a dedicated wellness application. Established in 2015, Cognetivity Neurosciences Ltd. maintains its headquarters in Vancouver, Canada. The organization was previously known as Utor Capital Corp. before adopting its current name in December 2017.
Aandeelprijs
$0.00733937
Laatst gesynchroniseerd: 2024-07-23
Marktkapitalisatie
$657.52K
Verandering (1 dag)
0.51%
Verandering (1 jaar)
0.00%
Land
CA
Handel Cognetivity Neurosciences Ltd. (CGN)

Categorie

Dividendrendementgeschiedenis voor Cognetivity Neurosciences Ltd. (CGN)
Het dividendrendement (TTM) van Cognetivity Neurosciences Ltd. (aandelsymbool: CGN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Cognetivity Neurosciences Ltd. (CGN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten